相似文献
1
Spread of integron-associated VIM-type metallo-beta-lactamase genes among imipenem-nonsusceptible Pseudomonas aeruginosa strains in Greek hospitals.
J Clin Microbiol. 2003 Feb;41(2):822-5. doi: 10.1128/JCM.41.2.822-825.2003.
2
Analysis of a novel class 1 integron containing metallo-beta-lactamase gene VIM-2 in Pseudomonas aeruginosa.
J Microbiol. 2009 Dec;47(6):753-9. doi: 10.1007/s12275-008-0272-2. Epub 2010 Feb 4.
3
Characterization of acquired beta-lactamases and their genetic support in multidrug-resistant Pseudomonas aeruginosa isolates in Taiwan: the prevalence of unusual integrons.
J Antimicrob Chemother. 2006 Sep;58(3):530-6. doi: 10.1093/jac/dkl266. Epub 2006 Jul 1.
4
bla(VIM-2) cassette-containing novel integrons in metallo-beta-lactamase-producing Pseudomonas aeruginosa and Pseudomonas putida isolates disseminated in a Korean hospital.
Antimicrob Agents Chemother. 2002 Apr;46(4):1053-8. doi: 10.1128/AAC.46.4.1053-1058.2002.
5
Characterization of a new integron containing bla(VIM-1) and aac(6')-IIc in an Enterobacter cloacae clinical isolate from Greece.
J Antimicrob Chemother. 2005 May;55(5):634-8. doi: 10.1093/jac/dki073. Epub 2005 Mar 10.
6
Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain.
Antimicrob Agents Chemother. 2008 Oct;52(10):3589-96. doi: 10.1128/AAC.00465-08. Epub 2008 Jul 21.
7
Integrons containing the VIM-2 metallo-beta-lactamase gene among imipenem-resistant Pseudomonas aeruginosa strains from different Chinese hospitals.
J Clin Microbiol. 2006 Nov;44(11):4242-5. doi: 10.1128/JCM.01558-06. Epub 2006 Sep 27.
8
Analysis of integrons and associated gene cassettes of metallo-β-lactamase-positive Pseudomonas aeruginosa in Malaysia.
J Med Microbiol. 2011 Jul;60(Pt 7):988-994. doi: 10.1099/jmm.0.029868-0. Epub 2011 Mar 24.
9
Identification and distribution of the clinical isolates of imipenem-resistant Pseudomonas aeruginosa carrying metallo-beta-lactamase and/or class 1 integron genes.
J Huazhong Univ Sci Technolog Med Sci. 2008 Jun;28(3):235-8. doi: 10.1007/s11596-008-0301-8. Epub 2008 Jun 19.
10
Characterisation of the first VIM metallo-beta-lactamase-producing Pseudomonas aeruginosa clinical isolate in Serbia.
Acta Microbiol Immunol Hung. 2008 Dec;55(4):447-54. doi: 10.1556/AMicr.55.2008.4.9.
引用本文的文献
1
Rapid Reversal of Carbapenemase-Producing Epidemiology from - to -harbouring Isolates in a Greek Tertiary Care Hospital.
Antibiotics (Basel). 2024 Aug 12;13(8):762. doi: 10.3390/antibiotics13080762.
2
Carrying Enterobacterales Harboring Antibiotic Resistance Genes.
Antibiotics (Basel). 2024 Mar 2;13(3):234. doi: 10.3390/antibiotics13030234.
3
Surveillance of Antimicrobial Resistance and Multidrug Resistance Prevalence of Clinical Isolates in a Regional Hospital in Northern Greece.
Antibiotics (Basel). 2023 Nov 5;12(11):1595. doi: 10.3390/antibiotics12111595.
4
Unravelling the Features of Success of VIM-Producing ST111 and ST235 in a Greek Hospital.
Microorganisms. 2020 Nov 28;8(12):1884. doi: 10.3390/microorganisms8121884.
5
Eight-year trends in the relative isolation frequency and antimicrobial susceptibility among bloodstream isolates from Greek hospitals: data from the Greek Electronic System for the Surveillance of Antimicrobial Resistance - WHONET-Greece, 2010 to 2017.
Euro Surveill. 2020 Aug;25(34). doi: 10.2807/1560-7917.ES.2020.25.34.1900516.
6
High quality 3C de novo assembly and annotation of a multidrug resistant ST-111 Pseudomonas aeruginosa genome: Benchmark of hybrid and non-hybrid assemblers.
Sci Rep. 2020 Jan 29;10(1):1392. doi: 10.1038/s41598-020-58319-6.
7
Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa in an endemic area: comparison with global data.
Eur J Clin Microbiol Infect Dis. 2018 Jul;37(7):1211-1220. doi: 10.1007/s10096-018-3244-4. Epub 2018 Apr 11.
8
Prevalence and Clonal Dissemination of Metallo-Beta-Lactamase-Producing Pseudomonas aeruginosa in Kermanshah.
Jundishapur J Microbiol. 2015 Jul 27;8(7):e20980. doi: 10.5812/jjm.20980v2. eCollection 2015 Jul.
9
Accumulation of carbapenem resistance mechanisms in VIM-2-producing Pseudomonas aeruginosa under selective pressure.
Eur J Clin Microbiol Infect Dis. 2014 Feb;33(2):253-8. doi: 10.1007/s10096-013-1952-3. Epub 2013 Sep 6.
10
Computational analysis of pathogen-borne metallo β-lactamases reveals discriminating structural features between B1 types.
BMC Res Notes. 2012 Feb 14;5:96. doi: 10.1186/1756-0500-5-96.
本文引用的文献
1
bla(VIM-2) cassette-containing novel integrons in metallo-beta-lactamase-producing Pseudomonas aeruginosa and Pseudomonas putida isolates disseminated in a Korean hospital.
Antimicrob Agents Chemother. 2002 Apr;46(4):1053-8. doi: 10.1128/AAC.46.4.1053-1058.2002.
2
Of Pseudomonas, porins, pumps and carbapenems.
J Antimicrob Chemother. 2001 Mar;47(3):247-50. doi: 10.1093/jac/47.3.247.
3
Molecular heterogeneity of bla(VIM-2)-containing integrons from Pseudomonas aeruginosa plasmids encoding the VIM-2 metallo-beta-lactamase.
FEMS Microbiol Lett. 2001 Feb 20;195(2):145-50. doi: 10.1111/j.1574-6968.2001.tb10512.x.
4
Characterization of Class 1 integrons from Pseudomonas aeruginosa that contain the bla(VIM-2) carbapenem-hydrolyzing beta-lactamase gene and of two novel aminoglycoside resistance gene cassettes.
Antimicrob Agents Chemother. 2001 Feb;45(2):546-52. doi: 10.1128/AAC.45.2.546-552.2001.
5
Carbapenem-hydrolysing VIM-2 metallo- beta-lactamase in Pseudomonas aeruginosa from Greece.
J Antimicrob Chemother. 2000 Dec;46(6):1041-2. doi: 10.1093/jac/46.6.1041.
6
Evaluation of random amplified polymorphic DNA typing of Pseudomonas aeruginosa.
J Clin Microbiol. 2000 Dec;38(12):4614-5. doi: 10.1128/JCM.38.12.4614-4615.2000.
7
Hospital outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-beta-lactamase.
Clin Infect Dis. 2000 Nov;31(5):1119-25. doi: 10.1086/317448. Epub 2000 Nov 6.
8
Carbapenemases: a problem in waiting?
Curr Opin Microbiol. 2000 Oct;3(5):489-95. doi: 10.1016/s1369-5274(00)00128-4.
9
Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France.
Antimicrob Agents Chemother. 2000 Apr;44(4):891-7. doi: 10.1128/AAC.44.4.891-897.2000.
10
Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece.
J Clin Microbiol. 2000 Mar;38(3):1290-2. doi: 10.1128/JCM.38.3.1290-1292.2000.
Zotero 插件